Importance: Approximately one-third of children who experience a concussion develop prolonged concussion symptoms. To our knowledge, there are currently no objective or easily administered tests for predicting prolonged concussion symptoms. Several studies have identified alterations in epigenetic molecules known as microRNAs (miRNAs) following traumatic brain injury. No studies have examined whether miRNA expression can detect prolonged concussion symptoms. Objective: To evaluate the efficacy of salivary miRNAs for identifying children with concussion who are at risk for prolonged symptoms. Design, Setting, and Participants: This prospective cohort study at the Penn State Medical Center observed 52 patients aged 7 to 21 years presenting for evaluation of concussion within 14 days of initial head injury, with follow-up at 4 and 8 weeks. Exposures: All patients had a clinical diagnosis of concussion. Main Outcomes and Measures: Salivary miRNA expression was measured at the time of initial clinical presentation in all patients. Patients with a Sport Concussion Assessment Tool (SCAT3) symptom score of 5 or greater on self-report or parent report 4 weeks after injury were designated as having prolonged symptoms. Results: Of the 52 included participants, 22 (42%) were female, and the mean (SD) age was 14 (3) years. Participants were split into the prolonged symptom group (n = 30) and acute symptom group (n = 22). Concentrations of 15 salivary miRNAs spatially differentiated prolonged and acute symptom groups on partial least squares discriminant analysis and demonstrated functional relationships with neuronal regulatory pathways. Levels of 5 miRNAs (miR-320c-1, miR-133a-5p, miR-769-5p, let-7a-3p, and miR-1307-3p) accurately identified patients with prolonged symptoms on logistic regression (area under the curve, 0.856; 95% CI, 0.822-0.890). This accuracy exceeded accuracy of symptom burden on child (area under the curve, 0.649; 95% CI, 0.388-0.887) or parent (area under the curve, 0.562; 95% CI, 0.219-0.734) SCAT3 score. Levels of 3 miRNAs were associated with specific symptoms 4 weeks after injury; miR-320c-1 was associated with memory difficulty (R, 0.55; false detection rate, 0.02), miR-629 was associated with headaches (R, 0.47; false detection rate, 0.04), and let-7b-5p was associated with fatigue (R, 0.45; false detection rate, 0.04). Conclusions and Relevance: Salivary miRNA levels may identify the duration and character of concussion symptoms. This could reduce parental anxiety and improve care by providing a tool for concussion management. Further validation of this approach is needed.
Importance: Approximately one-third of children who experience a concussion develop prolonged concussion symptoms. To our knowledge, there are currently no objective or easily administered tests for predicting prolonged concussion symptoms. Several studies have identified alterations in epigenetic molecules known as microRNAs (miRNAs) following traumatic brain injury. No studies have examined whether miRNA expression can detect prolonged concussion symptoms. Objective: To evaluate the efficacy of salivary miRNAs for identifying children with concussion who are at risk for prolonged symptoms. Design, Setting, and Participants: This prospective cohort study at the Penn State Medical Center observed 52 patients aged 7 to 21 years presenting for evaluation of concussion within 14 days of initial head injury, with follow-up at 4 and 8 weeks. Exposures: All patients had a clinical diagnosis of concussion. Main Outcomes and Measures: Salivary miRNA expression was measured at the time of initial clinical presentation in all patients. Patients with a Sport Concussion Assessment Tool (SCAT3) symptom score of 5 or greater on self-report or parent report 4 weeks after injury were designated as having prolonged symptoms. Results: Of the 52 included participants, 22 (42%) were female, and the mean (SD) age was 14 (3) years. Participants were split into the prolonged symptom group (n = 30) and acute symptom group (n = 22). Concentrations of 15 salivary miRNAs spatially differentiated prolonged and acute symptom groups on partial least squares discriminant analysis and demonstrated functional relationships with neuronal regulatory pathways. Levels of 5 miRNAs (miR-320c-1, miR-133a-5p, miR-769-5p, let-7a-3p, and miR-1307-3p) accurately identified patients with prolonged symptoms on logistic regression (area under the curve, 0.856; 95% CI, 0.822-0.890). This accuracy exceeded accuracy of symptom burden on child (area under the curve, 0.649; 95% CI, 0.388-0.887) or parent (area under the curve, 0.562; 95% CI, 0.219-0.734) SCAT3 score. Levels of 3 miRNAs were associated with specific symptoms 4 weeks after injury; miR-320c-1 was associated with memory difficulty (R, 0.55; false detection rate, 0.02), miR-629 was associated with headaches (R, 0.47; false detection rate, 0.04), and let-7b-5p was associated with fatigue (R, 0.45; false detection rate, 0.04). Conclusions and Relevance: Salivary miRNA levels may identify the duration and character of concussion symptoms. This could reduce parental anxiety and improve care by providing a tool for concussion management. Further validation of this approach is needed.
Authors: Jin-Wu Nam; Olivia S Rissland; David Koppstein; Cei Abreu-Goodger; Calvin H Jan; Vikram Agarwal; Muhammed A Yildirim; Antony Rodriguez; David P Bartel Journal: Mol Cell Date: 2014-03-13 Impact factor: 17.970
Authors: Mark R Zonfrillo; Christina L Master; Matthew F Grady; Flaura K Winston; James M Callahan; Kristy B Arbogast Journal: Pediatrics Date: 2012-11-12 Impact factor: 7.124
Authors: John B Redell; Anthony N Moore; Norman H Ward; Georgene W Hergenroeder; Pramod K Dash Journal: J Neurotrauma Date: 2010-11-23 Impact factor: 5.269
Authors: Biswadev Mitra; Thomas F Rau; Nanda Surendran; James H Brennan; Prasanthan Thaveenthiran; Edmond Sorich; Mark C Fitzgerald; Jeffrey V Rosenfeld; Sarjubhai A Patel Journal: J Clin Neurosci Date: 2017-01-20 Impact factor: 1.961
Authors: Steven D Hicks; Jeremiah Johnson; Molly C Carney; Harry Bramley; Robert P Olympia; Andrea C Loeffert; Neal J Thomas Journal: J Neurotrauma Date: 2017-10-27 Impact factor: 5.269
Authors: Pernille Jansen; Klaus Giehl; Jens R Nyengaard; Kenneth Teng; Oleg Lioubinski; Susanne S Sjoegaard; Tilman Breiderhoff; Michael Gotthardt; Fuyu Lin; Andreas Eilers; Claus M Petersen; Gary R Lewin; Barbara L Hempstead; Thomas E Willnow; Anders Nykjaer Journal: Nat Neurosci Date: 2007-10-14 Impact factor: 24.884
Authors: Linda Papa; Semyon M Slobounov; Hans C Breiter; Alexa Walter; Tim Bream; Peter Seidenberg; Julian E Bailes; Stephen Bravo; Brian Johnson; David Kaufman; Dennis L Molfese; Thomas M Talavage; David C Zhu; Barbara Knollmann-Ritschel; Manish Bhomia Journal: J Neurotrauma Date: 2018-12-05 Impact factor: 5.269
Authors: Abhinav Srinath; Ying Li; Romuald Girard; Issam A Awad; Sharbel G Romanos; Bingqing Xie; Chang Chen; Yan Li; Thomas Moore; Dehua Bi; Je Yeong Sone; Rhonda Lightle; Nick Hobson; Dongdong Zhang; Janne Koskimäki; Le Shen; Sara McCurdy; Catherine Chinhchu Lai; Agnieszka Stadnik; Kristina Piedad; Julián Carrión-Penagos; Abdallah Shkoukani; Daniel Snellings; Robert Shenkar; Dinanath Sulakhe; Yuan Ji; Miguel A Lopez-Ramirez; Mark L Kahn; Douglas A Marchuk; Mark H Ginsberg Journal: Transl Stroke Res Date: 2022-06-17 Impact factor: 6.829